Inchingolo Francesco, Inchingolo Angelo Michele, Piras Fabio, Ferrante Laura, Mancini Antonio, Palermo Andrea, Inchingolo Alessio Danilo, Dipalma Gianna
Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
College of Medicine and Dentistry, Birmingham B4 6BN, UK.
Healthcare (Basel). 2024 Aug 2;12(15):1537. doi: 10.3390/healthcare12151537.
Anticoagulant drugs are a valuable tool for minimizing thrombotic risks in at-risk patients. The purpose of this study is to conduct a literature review highlighting the management of these drugs during daily clinical dental practice.
We limited our search to English-language papers published between 1 January 1989, and 7 March 2024, in PubMed, Scopus and Web of Science that were relevant to our topic. In the search approach, the Boolean keywords "anticoagulant AND dentistry" were used.
Twenty-five clinical trials were included for final review from 623 articles obtained from the databases Web of Science (83), PubMed (382), and Scopus (158), eliminating duplicates and 79 off-topic items, resulting in 419 articles after removing 315 entries and confirming eligibility. Overall, these studies support the use of local hemostatic measures to manage the risk of bleeding in patients on anticoagulant therapy undergoing dental procedures and highlight the importance of greater education and collaboration among healthcare professionals.
Research and clinical investigation have improved understanding and management of dental procedures in patients undergoing anticoagulant or antiplatelet therapy. Hemostatic agents, clinical protocols, risk factors, and continuous education are essential for navigating the complexities of anticoagulant therapy, ensuring optimal outcomes and enhancing patient well-being.
抗凝药物是降低高危患者血栓形成风险的重要工具。本研究旨在进行文献综述，突出这些药物在日常临床牙科实践中的管理。
我们将搜索范围限制在1989年1月1日至2024年3月7日期间在PubMed、Scopus和Web of Science上发表的与我们主题相关的英文论文。在搜索方法中，使用了布尔关键词“抗凝剂与牙科”。
从Web of Science（83篇）、PubMed（382篇）和Scopus（158篇）数据库中获得的623篇文章中，排除重复项和79篇离题文章后，最终纳入25项临床试验进行综述，在去除315条记录并确认符合条件后，得到419篇文章。总体而言，这些研究支持使用局部止血措施来管理接受牙科手术的抗凝治疗患者的出血风险，并强调了医疗保健专业人员之间加强教育与合作的重要性。
研究和临床调查提高了对抗凝或抗血小板治疗患者牙科手术的理解和管理。止血剂、临床方案、风险因素和持续教育对于应对抗凝治疗的复杂性、确保最佳结果和提高患者福祉至关重要。
